You searched for "erection"

985 results found

Preoperative stenting compared to non‑stenting in ureteroscopy for urinary stone disease

Urolithiasis, one of the most prevalent urological conditions worldwide, significantly affects patients’ quality of life. In the United States, its lifetime prevalence is approximately 1 in 11, while global rates vary from 1% to 13%. The management of urolithiasis offers...

The scent of Ethiopia: a personal story part 2

In May/June 2016 we featured a wonderful account of Zeeshan Aslam’s first trip with Urolink to the Hawassa Referral Hospital in Ethiopia (see here). One year on we are delighted that Zeeshan has once again taken the time to provide...

Long-term oncologic outcomes of salvage cryoablation for rrPC

Of patients undergoing radiotherapy (RT) for prostate cancer (PC), at least 15-20% will experience recurrence. Although salvage prostatectomy achieves durable oncological outcomes at 10 years, it is associated with significantly high morbidity. Thus, the majority of men with radio-recurrent prostate...

Saints preserve us!

In this series of articles I am going to show you some of the exhibits contained in the Museum of Urology, hosted on the BAUS website www.baus.org.uk. A saint is a holy person; the word derives from the Latin word...

Bladder Health UK: Urinary Tract Infection and Bladder Pain Syndrome. A Patient-Centred Approach.

Registration is now open for Bladder Health UK’s study day for healthcare professionals! If you are a healthcare professional, join us for a day at this central London venue in which we focus on urinary tract infection and bladder pain syndrome! Learning hours certificates will be available after the event which can be used for revalidation. Registration £25.00 Special thanks to sponsors : Aspire Pharma, CliniMed, Consilient Health, Viatris

Metabolic stone disease for urology trainees

Urolithiasis continues to be a heavy burden on the worldwide medical infrastructure with an estimated 106 million cases recorded internationally in 2021 [1]. Whilst incidence rates have started to decline across Europe and high-income North America, there are emerging hotspots...

iMEDicare – Pelvic Health Naturally are on a mission

Since 2022, the team at iMEDicare has been scaling the highest peaks of various European nations to raise funds for a selection of their favourite charities. Their mountain adventures have so far taken them to the top of Scotland, Wales,...

Boosting the immune response to Bacillus Calmette-Guérin

In this issue of European Urology, Buisan et al. report early clinical and immunological outcomes of subcutaneous priming with the non-live mycobacterium tuberculosis RUTI vaccine prior to intravesical Bacillus Calmette-Guérin (BCG) in patients with non-muscle-invasive bladder cancer (NMIBC). The phase...

PARP inhibitors and prostate cancer

The discovery that BRCA1/2-deficient tumour cells are highly sensitive to poly-ADP ribose polymerase (PARP) inhibitors (PARPi) established the foundation of synthetic lethality in metastatic castration-resistant prostate cancer (mCRPC). The TOPARP-A trial confirmed clinical benefit, with PARPi activity largely restricted to...

Urology Podcasts and NotebookLM

Podcasts, downloadable or streamable digital audio / video shows, have surged in popularity over the last five years due to the ubiquity of smartphones, high-speed mobile networks, and accessible content creation technology. They offer on-the-go access to expert discussions, clinical...

Action Bladder Cancer UK – 2019 Report

ABC UK is a national charity working for bladder cancer patients. Set up in 2009 we work to raise awareness of bladder cancer and the issues faced by patients; we provide direct support for patients; we work to improve outcomes for...

Introduction to prostate cryotherapy

Introduction Cryotherapy was first described by Dr James Arnott in 1850 where he used crushed ice and salt to get temperatures as low as -24oC, in the treatment of cervical and breast tumours [1]. The literature on prostatic cryotherapy dates...